Specific roles for Group V secretory PLA2 in retinal iron-induced oxidative stress. Implications for age-related macular degeneration

Experimental Eye Research

Volumn 113, Issue , 2013, Pages 172-181

  Rodriguez Diez G ^a   Sanchez Campos S ^a   Giusto, N M ^a   Salvador, G A ^a  

^a UNIVERSIDAD NACIONAL DEL SUR   (Argentina)

Author keywords

Acyltransferases; AMD; Iron; Oxidative stress; PLA2; Retina

Indexed keywords

ACYLTRANSFERASE; CYCLOOXYGENASE 2; GROUP V SECRETORY PHOSPHOLIPASE A2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IRON; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLSERINE; PHOSPHOLIPID; SECRETORY PHOSPHOLIPASE A2; SYNAPTOTAGMIN I; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; COW; CYTOSOLIC FRACTION; FEMALE; IMMUNOPRECIPITATION; IRON OVERLOAD; NONHUMAN; OXIDATIVE STRESS; OXYGENATION; PRIORITY JOURNAL; RETINA; RETINA DEGENERATION; RETINA MACULA AGE RELATED DEGENERATION;

3-(4,5-DIMETHYLTHIAZOL-2-YL)-2,5-DIPHENYLTETRAZOLIUM BROMIDE; 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID; AA; ACYLTRANSFERASES; AGE-RELATED MACULAR DEGENERATION; AMD; ARACHIDONIC ACID; ARACHIDONOYL TRIFLUOROMETHYL KETONE; AT; ATK; B-CELL LYMPHOMA 2; BCL-2; BEL; BOVINE SERUM ALBUMIN; BROMOENOL LACTONE; BSA; CALCIUM-INDEPENDENT PHOSPHOLIPASE A(2); CARDIOLIPIN; CL; COX; CPLA(2); CYCLOOXYGENASE; CYT C; CYTOCHROME C; CYTOSOLIC PHOSPHOLIPASE A(2); DITHIOTHREITOL; DTT; EDTA; GAPDH; GLYCERALDEHYDE-3-PHOSPHATEDEHYDROGENASE; H&E; HAEMATOXILINE AND EOSINE STAIN; HEPES; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEINS; HNRNP; HORSERADISH PEROXIDASE; HRP; IMMUNOPRECIPITATES; IP; IPLA(2); IRON; LACTATE DEHYDROGENASE; LDH; MTT; N,N′-1,2-ETHANDIYLBIS[N-(CARBOXYMETHYL)GLYCINE] DISODIUM SALT; NF-ΚB; NUCLEAR FACTOR KAPPA B; OXIDATIVE STRESS; PA; PBS; PC; PE; PGE(2); PGF; PHENYLMETHYLSULFONYL FLUORIDE; PHOSPATIDYLINOSITOL; PHOSPHATE BUFFER SALINE; PHOSPHATIDIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLSERINE; PHOSPHOLIPASE A(2); PI; PLA(2); PMSF; PROSTAGLANDIN E(2); PROSTAGLANDIN F; PS; RETINA; SDS; SDS-PAGE; SECRETORY PHOSPHOLIPASE A(2); SODIUM DODECYL SULFATE; SODIUM DODECYL SULFATE-POLYACRYLMIDE GEL ELECTROPHORESIS; SPH; SPHINGOMYELIN; SPLA(2); SPLA(2) INHIBITOR; TBA; TBARS; THIOBARBITURIC ACID; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TTBS; TWEEN-TRIS BUFFER SALINE; YM 26734;

ACETYLATION; ACETYLTRANSFERASES; ANIMALS; BLOTTING, WESTERN; CATTLE; CYCLOOXYGENASE 2; CYTOSOL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME INHIBITORS; FERROUS COMPOUNDS; GROUP V PHOSPHOLIPASES A2; IRON OVERLOAD; MACULAR DEGENERATION; NF-KAPPA B; OXIDATIVE STRESS; PHOSPHATIDYLETHANOLAMINES; PHOSPHATIDYLINOSITOLS; PHOSPHATIDYLSERINES; PHOSPHOLIPASES A; RETINA;

EID: 84880393605     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2013.05.019     Document Type: Article

References (46)

1. Balboa M.A., Shirai Y., Gaietta G., Ellisman M.H., Balsinde J., Dennis E.A. Localization of Group V phospholipase A2 in caveolin-enriched granules in activated P388D1 macrophage-like cells. J.Biol. Chem. 2003, 278:48059-48065.
2. Bazan N.G., Colangelo V., Lukiw W.J. Prostaglandins and other lipid mediators in Alzheimer's disease. Prostaglandins Other Lipid Mediat. 2002, 68-69:197-210.
3. Blasiak J., Sklodowska A., Ulinska M., Szaflik J.P. Iron and age-related macular degeneration. Klin. Oczna. 2009, 111:174-177.
4. Blasiak J., Szaflik J., Szaflik J.P. Implications of altered iron homeostasis for age-related macular degeneration. Front. Biosci. 2011, 16:1551-1559.
5. Boilard E., Lai Y., Larabee K., Balestrieri B., Ghomashchi F., Fujioka D., Gobezie R., Coblyn J.S., Weinblatt M.E., Massarotti E.M., Thornhill T.S., Divangahi M., Remold H., Lambeau G., Gelb M.H., Arm J.P., Lee D.M. Anovel anti-inflammatory role for secretory phospholipase A2 in immune complex-mediated arthritis. EMBO Mol. Med. 2010, 2:172-187.
6. Boyanovsky B.B., Li X., Shridas P., Sunkara M., Morris A.J., Webb N.R. Bioactive products generated by Group V sPLA(2) hydrolysis of LDL activate macrophages to secrete pro-inflammatory cytokines. Cytokine 2010, 50:50-57.
7. Castagnet P.I., Giusto N.M. Acyl-CoA: lysophosphatidylcholine acyltransferase activity in bovine retina rod outer segments. Arch. Biochem. Biophys. 1997, 340:124-134.
8. Chakraborti S. Phospholipase A(2) isoforms: a perspective. Cell Signal 2003, 15:637-665.
9. Cindrova-Davies T., Spasic-Boskovic O., Jauniaux E., Charnock-Jones D.S., Burton G.J. Nuclear factor-kappa B, p38, and stress-activated protein kinase mitogen-activated protein kinase signaling pathways regulate proinflammatory cytokines and apoptosis in human placental explants in response to oxidative stress: effects of antioxidant vitamins. Am. J. Pathol. 2007, 170:1511-1520.
10. Curfs D.M., Ghesquiere S.A., Vergouwe M.N., van der Made I., Gijbels M.J., Greaves D.R., Verbeek J.S., Hofker M.H., de Winther M.P. Macrophage secretory phospholipase A2 group X enhances anti-inflammatory responses, promotes lipid accumulation, and contributes to aberrant lung pathology. J.Biol. Chem. 2008, 283:21640-21648.
11. Dunaief J.L. Iron induced oxidative damage as a potential factor in age-related macular degeneration: the Cogan Lecture. Invest. Ophthalmol. Vis. Sci. 2006, 47:4660-4664.
12. Dunaief J.L., Richa C., Franks E.P., Schultze R.L., Aleman T.S., Schenck J.F., Zimmerman E.A., Brooks D.G. Macular degeneration in a patient with aceruloplasminemia, a disease associated with retinal iron overload. Ophthalmology 2005, 112:1062-1065.
13. Folch J., Lees M., Sloane Stanley G.H. Asimple method for the isolation and purification of total lipids from animal tissues. J.Biol. Chem. 1957, 226:497-509.
14. Franchi A., Di G.G., Farina M., de los Santos A.R., Marti M.L., Gimeno M.A. Differential action of non-steroidal antiinflammatory drugs on human gallbladder cyclooxygenase and lipoxygenase. Medicina (B Aires) 2000, 60:580-586.
15. Hadziahmetovic M., Dentchev T., Song Y., Haddad N., He X., Hahn P., Pratico D., Wen R., Harris Z.L., Lambris J.D., Beard J., Dunaief J.L. Ceruloplasmin/hephaestin knockout mice model morphologic and molecular features of AMD. Invest. Ophthalmol. Vis. Sci. 2008, 49:2728-2736.
16. Hadziahmetovic M., Song Y., Ponnuru P., Iacovelli J., Hunter A., Haddad N., Beard J., Connor J.R., Vaulont S., Dunaief J.L. Age-dependent retinal iron accumulation and degeneration in hepcidin knockout mice. Invest. Ophthalmol. Vis. Sci. 2011, 52:109-118.
17. Hadziahmetovic M., Song Y., Wolkow N., Iacovelli J., Kautz L., Roth M.P., Dunaief J.L. Bmp6 regulates retinal iron homeostasis and has altered expression in age-related macular degeneration. Am. J. Pathol. 2011, 179:335-348.
18. Hahn P., Qian Y., Dentchev T., Chen L., Beard J., Harris Z.L., Dunaief J.L. Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:13850-13855.
19. He X., Hahn P., Iacovelli J., Wong R., King C., Bhisitkul R., Massaro-Giordano M., Dunaief J.L. Iron homeostasis and toxicity in retinal degeneration. Prog. Retin. Eye Res. 2007, 26:649-673.
20. Kell D.B. Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples. Arch. Toxicol. 2010, 84:825-889.
21. Kolko M., Rodriguez de Turco E.B., Diemer N.H., Bazan N.G. Neuronal damage by secretory phospholipase A2: modulation by cytosolic phospholipase A2, platelet-activating factor, and cyclooxygenase-2 in neuronal cells in culture. Neurosci. Lett. 2003, 338:164-168.
22. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
23. Loh A., Hadziahmetovic M., Dunaief J.L. Iron homeostasis and eye disease. Biochim. Biophys. Acta 2009, 1790:637-649.
24. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J.Biol. Chem. 1951, 193:265-275.
25. Lukinova N., Iacovelli J., Dentchev T., Wolkow N., Hunter A., Amado D., Ying G.S., Sparrow J.R., Dunaief J.L. Iron chelation protects the retinal pigment epithelial cell line ARPE-19 against cell death triggered by diverse stimuli. Invest. Ophthalmol. Vis. Sci. 2009, 50:1440-1447.
26. Mackenzie G.G., Oteiza P.I. Zinc and the cytoskeleton in the neuronal modulation of transcription factor NFAT. J.Cell. Physiol. 2007, 210:246-256.
27. Mateos M.V., Salvador G.A., Giusto N.M. Selective localization of phosphatidylcholine-derived signaling in detergent-resistant membranes from synaptic endings. Biochim. Biophys. Acta 2010, 1798:624-636.
28. Moses G.S., Jensen M.D., Lue L.F., Walker D.G., Sun A.Y., Simonyi A., Sun G.Y. Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease. J.Neuroinflammation 2006, 3:28.
29. Murakami M., Kudo I. Secretory phospholipase A2. Biol. Pharm. Bull. 2004, 27:1158-1164.
30. Murakami M., Taketomi Y., Sato H., Yamamoto K. Secreted phospholipase A2 revisited. J.Biochem. 2011, 150:233-255.
31. Oeckinghaus A., Hayden M.S., Ghosh S. Crosstalk in NF-kappaB signaling pathways. Nat. Immunol. 2011, 12:695-708.
32. Osborn M.T., Herrin K., Buzen F.G., Hurlburt B.K., Chambers T.C. Electrophoretic mobility shift assay coupled with immunoblotting for the identification of DNA-binding proteins. Biotechniques 1999, 27:887-890. 892.
33. Perez-Chacon G., Astudillo A.M., Balgoma D., Balboa M.A., Balsinde J. Control of free arachidonic acid levels by phospholipases A2 and lysophospholipid acyltransferases. Biochim. Biophys. Acta 2009, 1791:1103-1113.
34. Richardson D.R. Novel chelators for central nervous system disorders that involve alterations in the metabolism of iron and other metal ions. Ann. N. Y. Acad. Sci. 2004, 1012:326-341.
35. Rodríguez Diez G., Uranga R.M., Mateos M.V., Giusto N.M., Salvador G.A. Differential participation of phospholipase A(2) isoforms during iron-induced retinal toxicity. Implications for age-related macular degeneration. Neurochem. Int. 2012, 61:749-758.
36. Rotstein N.P., Ilincheta de Boschero M.G., Giusto N.M., Aveldano M.I. Effects of aging on the composition and metabolism of docosahexaenoate-containing lipids of retina. Lipids 1987, 22:253-260.
37. Ruiperez V., Casas J., Balboa M.A., Balsinde J. Group V phospholipase A2-derived lysophosphatidylcholine mediates cyclooxygenase-2 induction in lipopolysaccharide-stimulated macrophages. J.Immunol. 2007, 179:631-638.
38. Ruland J. Return to homeostasis: downregulation of NF-kappaB responses. Nat. Immunol. 2011, 12:709-714.
39. Saegusa J., Akakura N., Wu C.Y., Hoogland C., Ma Z., Lam K.S., Liu F.T., Takada Y.K., Takada Y. Pro-inflammatory secretory phospholipase A2 type IIA binds to integrins alphavbeta3 and alpha4beta1 and induces proliferation of monocytic cells in an integrin-dependent manner. J.Biol. Chem. 2008, 283:26107-26115.
40. Salvador G.A., Oteiza P.I. Iron overload triggers redox-sensitive signals in human IMR-32 neuroblastoma cells. Neurotoxicology 2011, 32:75-82.
41. Seilhamer J.J., Pruzanski W., Vadas P., Plant S., Miller J.A., Kloss J., Johnson L.K. Cloning and recombinant expression of phospholipase A2 present in rheumatoid arthritic synovial fluid. J.Biol. Chem. 1989, 264:5335-5338.
42. Sen R. The origins of NF-kappaB. Nat. Immunol. 2011, 12:686-688.
43. Smale S.T. Hierarchies of NF-kappaB target-gene regulation. Nat. Immunol. 2011, 12:689-694.
44. 4 in rat cerebral cortex synaptic endings. J.Neurosci. Res. 2007, 85:2924-2932.
45. Whitnall M., Suryo R.Y., Huang M.L., Saletta F., Lok H.C., Gutierrez L., Lazaro F.J., Fleming A.J., St Pierre T.G., Mikhael M.R., Ponka P., Richardson D.R. Identification of nonferritin mitochondrial iron deposits in a mouse model of Friedreich ataxia. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:20590-20595.
46. Youdim M.B., Fridkin M., Zheng H. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases. Mech. Ageing Dev. 2005, 126:317-326.